| APA |
Gören, K., Bağlan, M., & Yıldıko, Ü. (2024). Melanoma Cancer Evaluation with ADME and Molecular Docking Analysis, DFT Calculations of (E)-methyl 3-(1-(4-methoxybenzyl)-2,3-dioxoindolin-5-yl)-acrylate Molecule. Journal of the Institute of Science and Technology, 14(3), 1186-1199. https://doi.org/10.21597/jist.1467666
|
|
| AMA |
1.Gören K, Bağlan M, Yıldıko Ü. Melanoma Cancer Evaluation with ADME and Molecular Docking Analysis, DFT Calculations of (E)-methyl 3-(1-(4-methoxybenzyl)-2,3-dioxoindolin-5-yl)-acrylate Molecule. J. Inst. Sci. and Tech. 2024;14(3):1186-1199. doi:10.21597/jist.1467666
|
|
| Chicago |
Gören, Kenan, Mehmet Bağlan, and Ümit Yıldıko. 2024. “Melanoma Cancer Evaluation With ADME and Molecular Docking Analysis, DFT Calculations of (E)-Methyl 3-(1-(4-Methoxybenzyl)-2,3-Dioxoindolin-5-Yl)-Acrylate Molecule”. Journal of the Institute of Science and Technology 14 (3): 1186-99. https://doi.org/10.21597/jist.1467666.
|
|
| EndNote |
Gören K, Bağlan M, Yıldıko Ü (September 1, 2024) Melanoma Cancer Evaluation with ADME and Molecular Docking Analysis, DFT Calculations of (E)-methyl 3-(1-(4-methoxybenzyl)-2,3-dioxoindolin-5-yl)-acrylate Molecule. Journal of the Institute of Science and Technology 14 3 1186–1199.
|
|
| IEEE |
[1]K. Gören, M. Bağlan, and Ü. Yıldıko, “Melanoma Cancer Evaluation with ADME and Molecular Docking Analysis, DFT Calculations of (E)-methyl 3-(1-(4-methoxybenzyl)-2,3-dioxoindolin-5-yl)-acrylate Molecule”, J. Inst. Sci. and Tech., vol. 14, no. 3, pp. 1186–1199, Sept. 2024, doi: 10.21597/jist.1467666.
|
|
| ISNAD |
Gören, Kenan - Bağlan, Mehmet - Yıldıko, Ümit. “Melanoma Cancer Evaluation With ADME and Molecular Docking Analysis, DFT Calculations of (E)-Methyl 3-(1-(4-Methoxybenzyl)-2,3-Dioxoindolin-5-Yl)-Acrylate Molecule”. Journal of the Institute of Science and Technology 14/3 (September 1, 2024): 1186-1199. https://doi.org/10.21597/jist.1467666.
|
|
| JAMA |
1.Gören K, Bağlan M, Yıldıko Ü. Melanoma Cancer Evaluation with ADME and Molecular Docking Analysis, DFT Calculations of (E)-methyl 3-(1-(4-methoxybenzyl)-2,3-dioxoindolin-5-yl)-acrylate Molecule. J. Inst. Sci. and Tech. 2024;14:1186–1199.
|
|
| MLA |
Gören, Kenan, et al. “Melanoma Cancer Evaluation With ADME and Molecular Docking Analysis, DFT Calculations of (E)-Methyl 3-(1-(4-Methoxybenzyl)-2,3-Dioxoindolin-5-Yl)-Acrylate Molecule”. Journal of the Institute of Science and Technology, vol. 14, no. 3, Sept. 2024, pp. 1186-99, doi:10.21597/jist.1467666.
|
|
| Vancouver |
1.Gören K, Bağlan M, Yıldıko Ü. Melanoma Cancer Evaluation with ADME and Molecular Docking Analysis, DFT Calculations of (E)-methyl 3-(1-(4-methoxybenzyl)-2,3-dioxoindolin-5-yl)-acrylate Molecule. J. Inst. Sci. and Tech. [Internet]. 2024 Sept. 1;14(3):1186-99. Available from: https://izlik.org/JA59ED95ZW
|
|